BOSTON and SAN CARLOS, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc., a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Pyxis One, a California-based tech startup that aims to revolutionize marketing and consumer intelligence by providing an all-in-one, codeless AI platform, closed ...
New cinematic monitoring solution for Blackmagic PYXIS cameras with bright HDR touchscreen, camera control and multiple mounting points! AMSTERDAM--(BUSINESS WIRE)--IBC 2024 - Blackmagic Design today ...
While one might expect a positive readout from a biotech’s lead candidate to boost the company’s stock price, Pyxis Oncology’s shares—which have tumbled more than 40% this week—tell a different story.
Pyxis Oncology, Inc. is reallocating its resources to focus on the development of its leading asset, PYX-201, a pioneering antibody-drug conjugate (ADC) showing promising efficacy in treating head and ...
The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results